Sydney Lupkin
Stories
-
Health
Blockbuster drug Humira finally faces lower-cost rivals
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
-
National
Copycat drugs could end Humira's reign as the prominent arthritis treatment
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign.
-
Health
Here's what really happened during the abortion drug's approval 23 years ago
A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.
-
Health
FDA pulls the only approved drug for preventing premature birth off the market
The drug had been fast-tracked for approval under the agency's accelerated approval program, and has been available for more than a decade, despite the drugmaker's failure to prove that it works.
-
Health
Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured
Once U.S. stockpiles of COVID-19 vaccine run out, Moderna says it might charge as much as $130 per dose, but give people who lack health insurance a break. Critics say that's not enough help.
-
Adderall shortage forces some patients to scramble, ration or go without
The FDA announced the supply troubles in the fall. Four months later, the medication remains hard to get and could stay that way until the spring
-
Health
Is it time for a reality check on rapid COVID tests?
At-home rapid tests have become a staple of COVID-19 precautions, but some experts worry that people are relying too much on these tests and that's creating a false sense of security.
-
National
Abortion pills should be easier to get. That doesn't mean that they will be
Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.
-
Health
5 things to know about the FDA's flawed approach to accelerated drug approvals
An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.
-
Politics
2 House subcommittees are trying to get answers about the baby formula shortage
Two House subcommittees are holding hearings on the baby formula crisis. One will focus on the Food and Drug Administration and the formula makers. The other will look at the effects of the shortage.